Christopher Eckstein

6PUBLICATIONS
14CO-AUTHORS
Neurology and neuromuscular diseasesMedical virologyNanomedicineOptometryAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 21, 2026
Natalizumab is associated with improved relapse outcomes and lower healthcare utilization versus ocrelizumab in treatment-naïve people with multiple sclerosis.

|May 08, 2026
Clinical Reasoning: A 28-Year-Old Man With Seizures and Thalamic Lesions.

|Nov 20, 2024
Catatonia in anti-NMDA receptor encephalitis: a case series and approach to improve outcomes with electroconvulsive therapy.

F Gabriela Kraiter, Dakota T May, Ryan D Slauer

|Aug 29, 2022
Journal Club: Neurofilament Light Chain Levels in Anti-NMDAR Encephalitis and Primary Psychiatric Psychosis.

M Elizabeth Deerhake, James Giarraputo, Megha Gupta

|Jan 21, 2022
Leber's Hereditary Optic Neuropathy Plus Causing Recurrent Myelopathy due to an MT-DN1 Mutation at G3635A.

Elijah Lackey, Ariel Lefland, Christopher Eckstein

|Aug 04, 2018
Nivolumab-Induced Autoimmune Encephalitis in Two Patients with Lung Adenocarcinoma.

Suma Shah, Anastasie Dunn-Pirio, Matthew Luedke

Pageof 1

Frequent Collaborators

2 joint publications

Suma Shah

1 joint publications

Elijah Lackey

1 joint publications

M Elizabeth Deerhake

1 joint publications

James Giarraputo